• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏中铁的分布可预测慢性丙型肝炎感染对干扰素治疗的反应。

Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.

作者信息

Barton A L, Banner B F, Cable E E, Bonkovsky H L

机构信息

Department of Pathology, University of Massachusetts Medical Center, Worcester 01655-0125, USA.

出版信息

Am J Clin Pathol. 1995 Apr;103(4):419-24. doi: 10.1093/ajcp/103.4.419.

DOI:10.1093/ajcp/103.4.419
PMID:7537017
Abstract

Recent evidence suggests that patients with chronic hepatitis C virus (CHCV) who respond to interferon-alpha (IFN) therapy have a lower hepatic iron concentration than those who do not. The object of this study was to assess the concentration and distribution of iron in liver biopsies from 15 patients with CHCV seen at the authors' medical center between June 1992 and March 1993. Patients with complete response to IFN were compared to those with non-complete response with respect to quantitative hepatic iron concentration, serum iron indices, and a detailed analysis of histologic features of hematoxylin-and-eosin and iron-stained pre-IFN biopsies. Patients with non-complete response had significantly higher scores for stainable iron in sinusoidal cells (P = .02) and portal tracts (P = .05) than did patients with complete response. Total hepatic iron scores, mean quantitative hepatic iron, and mean serum ferritin were higher in patients with noncomplete response, but the differences were not significant. In conclusion, iron deposition in sinusoidal cells and portal tracts is significantly less frequent in patients with complete response to IFN than in those with poor or no response, and may be a useful, objective predictor of response to IFN therapy.

摘要

最近有证据表明,对α干扰素(IFN)治疗有反应的慢性丙型肝炎病毒(CHCV)患者的肝脏铁浓度低于无反应者。本研究的目的是评估1992年6月至1993年3月在作者所在医疗中心就诊的15例CHCV患者肝活检中铁的浓度和分布情况。将对IFN完全反应的患者与未完全反应的患者在肝脏铁定量浓度、血清铁指标以及对苏木精-伊红染色和铁染色的IFN治疗前活检组织学特征进行详细分析方面进行比较。未完全反应的患者在窦状隙细胞(P = 0.02)和汇管区(P = 0.05)中可染色铁的评分显著高于完全反应的患者。未完全反应患者的肝脏总铁评分、平均肝脏铁定量和平均血清铁蛋白较高,但差异不显著。总之,对IFN完全反应的患者窦状隙细胞和汇管区的铁沉积频率明显低于反应不佳或无反应的患者,可能是IFN治疗反应的一个有用的客观预测指标。

相似文献

1
Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.肝脏中铁的分布可预测慢性丙型肝炎感染对干扰素治疗的反应。
Am J Clin Pathol. 1995 Apr;103(4):419-24. doi: 10.1093/ajcp/103.4.419.
2
A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.对Knodell评分及其他组织学参数作为慢性丙型肝炎干扰素治疗反应预测指标的详细分析。
Mod Pathol. 1995 Apr;8(3):232-8.
3
Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.
Am J Gastroenterol. 1996 Jul;91(7):1367-73.
4
Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.肝铁浓度不能预测慢性丙型肝炎患者对标准干扰素和聚乙二醇化干扰素/利巴韦林治疗的反应。
J Hepatol. 2004 Jun;40(6):1018-22. doi: 10.1016/j.jhep.2004.02.030.
5
Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver.
Biol Trace Elem Res. 2000 Feb;73(2):151-62. doi: 10.1385/BTER:73:2:151.
6
Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.血清透明质酸可预测慢性丙型肝炎患者对α干扰素治疗的反应。
Hepatogastroenterology. 1995 Sep-Oct;42(5):522-7.
7
Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.肝铁含量对乙型和丙型肝炎肝炎症及纤维化的阈值效应
J Hepatol. 1996 Nov;25(5):633-8. doi: 10.1016/s0168-8278(96)80231-5.
8
Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.慢性丙型肝炎的组织学特征评估及干扰素治疗结果
J Gastroenterol. 1996 Feb;31(1):69-74. doi: 10.1007/BF01211189.
9
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Hepatology. 2000 Mar;31(3):730-6. doi: 10.1002/hep.510310325.
10
Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.成功的干扰素治疗可逆转慢性丙型肝炎中肝脏铁蓄积增强和脂质过氧化的情况。
Am J Gastroenterol. 2000 Apr;95(4):1041-50. doi: 10.1111/j.1572-0241.2000.01979.x.

引用本文的文献

1
The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus.微量营养素在丙型肝炎病毒感染及后续反应中的作用。
Cells. 2019 Jun 17;8(6):603. doi: 10.3390/cells8060603.
2
Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C.慢性丙型肝炎患者血清中 hepcidin 减少导致铁蛋白 1 上调,从而增加十二指肠铁吸收。
Can J Gastroenterol Hepatol. 2018 Aug 14;2018:2154361. doi: 10.1155/2018/2154361. eCollection 2018.
3
Iron, HCV and the liver.
铁、丙型肝炎病毒与肝脏
World J Gastroenterol. 1997 Jun 15;3(2):61-3. doi: 10.3748/wjg.v3.i2.61.
4
Liver pathology of hepatitis C, beyond grading and staging of the disease.丙型肝炎的肝脏病理学,超越疾病的分级和分期。
World J Gastroenterol. 2016 Jan 28;22(4):1357-66. doi: 10.3748/wjg.v22.i4.1357.
5
Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.室温磁化率可预测血清铁蛋白升高患者的肝活检铁含量。
Ann Hepatol. 2012 Jan-Feb;11(1):77-84.
6
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.肝细胞和门脉区细胞的铁含量可预测慢性丙型肝炎进展和患者结局。
Gastroenterology. 2011 May;140(5):1490-500.e3. doi: 10.1053/j.gastro.2011.01.053. Epub 2011 Feb 15.
7
The effect of iron depletion on chronic hepatitis C virus infection.缺铁对慢性丙型肝炎病毒感染的影响。
Hepatol Int. 2008 Sep;2(3):335-40. doi: 10.1007/s12072-008-9076-z. Epub 2008 May 8.
8
Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus.铁可增强丙型肝炎病毒内部核糖体进入位点所介导的翻译起始过程。
Virus Genes. 2008 Oct;37(2):154-60. doi: 10.1007/s11262-008-0250-0. Epub 2008 Jun 20.
9
Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C.长期放血疗法联合低铁饮食疗法可降低慢性丙型肝炎发展为肝细胞癌的风险。
J Gastroenterol. 2007 Oct;42(10):830-6. doi: 10.1007/s00535-007-2095-z. Epub 2007 Oct 15.
10
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.放血疗法可改善慢性丙型肝炎患者对干扰素的治疗反应:六项前瞻性随机对照试验的荟萃分析。
Dig Dis Sci. 2008 Mar;53(3):815-22. doi: 10.1007/s10620-007-9945-7. Epub 2007 Sep 12.